Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L36a pseudogene 6 (RPL36AP6)
- Target
- RPL36AP6
- Molecular classification
- Other (Pseudogene)
01
Overview
RPL36AP6 is a human pseudogene, officially named "ribosomal protein L36a pseudogene 6". It is a noncoding genomic sequence with high similarity to the protein-coding RPL36A gene, which encodes a structural ribosomal protein of the 60S subunit. However, RPL36AP6 itself does not produce a functional protein, and its role is typically considered limited to possible noncoding RNA-related regulation (such as involvement in microRNA or siRNA pathways), though no specific regulatory function has been directly demonstrated for this pseudogene. It is not considered a therapeutic target, nor does it have established disease associations, known drug interactions, or biomarker utility. Its most common aliases are RPL36A_12_1002 and bA380I20.1.
- Other names
- RPL36A_12_1002bA380I20.1
02
Mechanism of action
None (No known mechanism of action for drugs targeting this pseudogene)
03
Biological functions
Potential regulatory roles via noncoding RNA mechanisms, but no direct involvement in coding protein functionPseudogene transcripts can sometimes participate in regulatory functions such as acting as miRNA decoys or producing siRNAs that modulate gene expressionThere is no direct experimental evidence for RPL36AP6 itself aside from being classified as a pseudogene
04
Disease associations
Other (No direct disease associations specific to RPL36AP6 pseudogene)Its parent protein (RPL36A) is associated with cancer and other diseases, but the pseudogene is not
05
Safety considerations
None (No relevant safety concerns as there are no therapeutic agents that directly target RPL36AP6)
Beyond the preview
Go deeper on Ribosomal protein L36a pseudogene 6 (RPL36AP6).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L36a pseudogene 6 (RPL36AP6).